Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials
Introduction and Objectives: Practicing physicians often hesitate to use statins and/or other lipid-lowering therapies in NAFLD due to concern for hepatotoxicity. The aim of this study is to examine the safety of lipid lowering therapies in NAFLD patients. Materials and Methods: Data from randomized...
Main Authors: | Mohamed Abdallah, Landon Brown, John Provenza, Raseen Tariq, Smitha Gowda, Ashwani K. Singal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268122000801 |
Similar Items
-
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
by: Steven Young, et al.
Published: (2020-07-01) -
Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis
by: Aiping Liu, et al.
Published: (2023-04-01) -
Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD
by: Maria Mavromati, et al.
Published: (2021-11-01) -
Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies
by: Ashwani K. Singal, et al.
Published: (2023-01-01) -
Resolution rates in clinical trials for microbiota restoration for recurrent infection: an updated systematic review and meta-analysis
by: Raseen Tariq, et al.
Published: (2023-05-01)